Grail, Inc. (NASDAQ:GRAL - Get Free Report) reached a new 52-week high on Friday . The company traded as high as $31.59 and last traded at $31.51, with a volume of 1479432 shares changing hands. The stock had previously closed at $26.67.
Analyst Ratings Changes
GRAL has been the topic of a number of research analyst reports. Morgan Stanley initiated coverage on Grail in a report on Wednesday, November 27th. They set an "equal weight" rating and a $16.00 price target on the stock. Guggenheim began coverage on Grail in a research note on Thursday, October 17th. They issued a "neutral" rating on the stock. Finally, Wolfe Research began coverage on Grail in a research report on Friday, November 15th. They issued a "peer perform" rating on the stock.
Get Our Latest Stock Report on GRAL
Grail Price Performance
The stock's fifty day moving average is $20.34 and its 200 day moving average is $16.64.
Grail (NASDAQ:GRAL - Get Free Report) last posted its quarterly earnings results on Tuesday, November 12th. The company reported ($3.94) earnings per share for the quarter. The firm had revenue of $28.65 million for the quarter. On average, research analysts expect that Grail, Inc. will post -65.16 earnings per share for the current year.
Insiders Place Their Bets
In other Grail news, CFO Aaron Freidin sold 30,452 shares of the firm's stock in a transaction on Monday, November 18th. The stock was sold at an average price of $14.02, for a total value of $426,937.04. Following the transaction, the chief financial officer now owns 268,277 shares in the company, valued at approximately $3,761,243.54. This trade represents a 10.19 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Wesbanco Bank Inc. purchased a new position in shares of Grail during the 4th quarter worth $523,000. Slow Capital Inc. acquired a new position in shares of Grail during the fourth quarter worth about $2,379,000. Perigon Wealth Management LLC acquired a new position in shares of Grail during the fourth quarter worth about $260,000. 180 Wealth Advisors LLC acquired a new position in shares of Grail during the fourth quarter worth about $1,681,000. Finally, Douglas Lane & Associates LLC acquired a new position in Grail in the fourth quarter valued at approximately $3,034,000.
Grail Company Profile
(
Get Free Report)
GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.
Further Reading
Before you consider Grail, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Grail wasn't on the list.
While Grail currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
